Del Mar Pharmaceuticals Plans Clinical Trials for GBM Treatment
DMP estimates that the market for treating GBM patients post front-line therapy exceeds US$200 million annually in North America.
onemedforum
Promising Medical Technologies from Leading Universities to Showcase at 5th Annual OneMedForum
Significant Advances in Translational Medicine Result from “Coulter Process”.
Sector Reports on Investment Opportunities in Health and Medicine Featured at 5th Annual OneMedForum
OneMedPlace announced today that OneMedForum San Francisco 2012 will feature special reports in 8 healthcare sectors.
Protected: VIDEO: Talking JOBS Act with Christine Jacobs, SEC Advisory Committee Chair
There is no excerpt because this is a protected post.
Aduro Biotech, OneMedForum SF Presenting Company, Announces $20 Million Financing
Aduro BioTech, a OneMedForum presenting company is engineering Listeria to treat Pancreatic Cancer and other infectious diseases.
Is Europe A Better Place To Build A Medical Technology Company? (Video)
Growth in the life sciences industries will greatly depend on how the FDA responds to growing complaints that they are stifling medical technologies.
S.E.A. Medical Tackles IV Errors Before They Occur
In 2006, 2-year-old Emily Jerry was killed when a technician mixed her chemotherapy drug with a saline solution 26 times above normal.
And The Beat Goes On: Lifesaving Heart Surgery Technology Unveiled
The very life support system that carries a person throughout his or her life, the heart is one of the first things to develop in a fetus.
OneMedPlace Brings 17 Diverse Workshop Sessions With New Inspirations To All Involved
This year at OneMedForum San Francisco, OneMedPlace offered 17 workshop sessions on a variety of subjects helping investors grow their businesses.
Day 1 at the OneMedForum 2011
The 4th Annual OneMedForum started on January 11th, 2011 with a large gathering of healthcare financiers and executives filling out the Sir Frances Drake Hotel in San Francisco.